Astrazeneca PLC Sponsored ADR (AZN)

51.95
2.50 4.60
NASDAQ
Prev Close 54.44
Open 53.37
Day Low/High 52.03 / 53.43
52 Wk Low/High 36.15 / 64.94
Volume 14.53M
Exchange NASDAQ
P/E Ratio 51.70
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: Here's My Plan to Distribute the Vaccine

Jim Cramer: Here's My Plan to Distribute the Vaccine

We have to take both the private sector and the states out of the equation, and adopt the process that wiped out Polio.

Assessing AstraZeneca in the Fight Against the Virus

Assessing AstraZeneca in the Fight Against the Virus

While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.

$2000 Delayed, Covid-19 Mutation, Trading Intel

$2000 Delayed, Covid-19 Mutation, Trading Intel

I did something on Tuesday that I never thought that I would do again. I bought some Intel.

I've Come Around to Thinking of Boeing as an Investment

I've Come Around to Thinking of Boeing as an Investment

I think BA returns to normal as we do, as the airlines do... but with the defense contracting business as a foundation to rely upon.

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

The Russell 2000 is now up 7% for December, twice the increase for the Nasdaq Composite.

Jim Cramer: Market Sees Successful Vaccine Rollout as a Long Shot

Jim Cramer: Market Sees Successful Vaccine Rollout as a Long Shot

Ending the pandemic swiftly appears unlikely, so here's how to look at key stocks and sectors right now -- especially as concerns of new lockdowns grow.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.

A Glance Behind, Sifting Through Events to Come, Waiting for Santa

A Glance Behind, Sifting Through Events to Come, Waiting for Santa

Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights

Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.

Real Money Post Industrial Average Climbs 9.5% Over November

Real Money Post Industrial Average Climbs 9.5% Over November

The RMPIA also tops other indexes for year, shooting ahead 29%.

What If AstraZeneca's Covid-19 Vaccine Doesn't Work?

What If AstraZeneca's Covid-19 Vaccine Doesn't Work?

Governments around the world have committed to buying hundreds of millions of doses of AZD1222.

Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting

Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting

The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.

Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000

Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000

All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.

November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks

November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks

Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.

Jim Cramer: If the End of the Covid Era Is in Sight, Here Are the Stocks to Buy

Jim Cramer: If the End of the Covid Era Is in Sight, Here Are the Stocks to Buy

I will come back to these names over and over again as we are now in the sweet spot for many.

Big News Is Followed by Little Moves

Big News Is Followed by Little Moves

A lot has happened over the past couple weeks, but little has changed. Let's dig in.

Jim Cramer: Just How Will the Covid-19 Vaccines Be Distributed?

Jim Cramer: Just How Will the Covid-19 Vaccines Be Distributed?

None of these questions have been answered which is why I see chaos ahead as we can't even imagine this process working.

Broadening Market Performance, the Vaccine 'Put', Trading McKesson

Broadening Market Performance, the Vaccine 'Put', Trading McKesson

Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.

Asia's Worst-Performing Stock Market Suddenly Becomes Its Best

Asia's Worst-Performing Stock Market Suddenly Becomes Its Best

The stock market in the Philippines has surged by one-fifth in just over a month amid reasons for optimism.

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.

The Trap Door, Winter Arrives Early, Lesson of Hiroo Onoda, Fading Consumer

The Trap Door, Winter Arrives Early, Lesson of Hiroo Onoda, Fading Consumer

Technical analysis has become so much more accurate a trading tool than it ever was before.

It's Finally Time for Energy Stocks

It's Finally Time for Energy Stocks

One of the most-hated sectors of the market is taking off, and it's not too late to get on board.

Election Hindsight, Treasury Yields, Fed Day, Chip Stock Setup, A Great Trade

Election Hindsight, Treasury Yields, Fed Day, Chip Stock Setup, A Great Trade

The most important market takeaway right now is that both the Nasdaq Composite and S&P 500 have filled their respective gaps and retaken their 50-day simple moving averages.

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

Now, that we have confirmation from the Nasdaq Composite, I think we can say equity markets are indeed back in what I would consider an uptrend.